siRNA-mediated regulation indicates that extensive complementarity is not always required (24), leaving open the possibility that a large fraction of metazoan miRNA regulation might be achieved through mRNA cleavage. Acting as a signal, hydrogen peroxide circumvents antioxidant defense by overoxidizing peroxiredoxins (Prxs), the enzymes that metabolize peroxides. We show that sestrins, a family of proteins whose expression is modulated by p53, are required for regeneration of Prxs containing Cys-SO 2 H, thus reestablishing the antioxidant firewall. Sestrins contain a predicted redox-active domain homologous to AhpD, the enzyme catalyzing the reduction of a bacterial Prx, AhpC. Purified Hi95 (sestrin 2) protein supports adenosine triphosphate-dependent reduction of overoxidized PrxI in vitro, indicating that unlike AhpD, which is a disulfide reductase, sestrins are cysteine sulfinyl reductases. As modulators of peroxide signaling and antioxidant defense, sestrins constitute potential therapeutic targets.
Acting as a signal, hydrogen peroxide circumvents antioxidant defense by overoxidizing peroxiredoxins (Prxs), the enzymes that metabolize peroxides. We show that sestrins, a family of proteins whose expression is modulated by p53, are required for regeneration of Prxs containing Cys-SO 2 H, thus reestablishing the antioxidant firewall. Sestrins contain a predicted redox-active domain homologous to AhpD, the enzyme catalyzing the reduction of a bacterial Prx, AhpC. Purified Hi95 (sestrin 2) protein supports adenosine triphosphate-dependent reduction of overoxidized PrxI in vitro, indicating that unlike AhpD, which is a disulfide reductase, sestrins are cysteine sulfinyl reductases. As modulators of peroxide signaling and antioxidant defense, sestrins constitute potential therapeutic targets.
Reactive oxygen and nitrogen species (ROS and RNS, respectively) are by-products of metabolism that are destroyed by antioxidant systems. However, the same compounds function as important signal-transducing messengers. Hydrogen peroxide bursts are elicited by ligand-receptor interaction in major pathways, which include mitogenactivated protein kinase and nuclear factor B pathways (1), affecting cell proliferation and cell death. Antioxidant mechanisms must be thus tightly regulated to enable signaling but prevent oxidative damage. Peroxiredoxins (Prxs), a family of thiolcontaining peroxidases conserved from bacteria to mammals (2) , are major reductants of endogenously produced peroxides in eukaryotes (3) . In addition, Prxs catalyze decomposition of RNS (4) (5) (6) (7) . How do hydrogen peroxide signals evade this antioxidant defense? The answer seems to lie in the structure of eukaryotic 2-Cys Prxs (8) which, 1 Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. 2 Engelhardt Institute of Molecular Biology, 119991, Moscow, Russia. 3 Cancer Research Center, 1154785 Moscow, Russia. 4 Quark Biotech Incorporated, Ness Ziona, 70400 Israel. 5 National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA. *These authors contributed equally to this work.
†To whom corresponding should be addressed. Email: chumakp@ccf.org unlike their prokaryotic ancestors, have acquired increased sensitivity to inactivation through overoxidation of the catalytic center (9, 10) . During background scavenging, the peroxidatic cysteine is oxidized to Cys-SOH, which forms a disulfide bridge with the resolving cysteine located in the other subunit of the Prx dimer. This disulfide bond is then reduced by thioredoxin (11) (12) (13) . However, because the formation of the resolving disulfide bond is slow, high concentrations of ROS cause further oxidation of the peroxidatic cysteine to Cys-SO 2 H, yielding an inactive form of Prx that cannot be reduced by thioredoxin (8) . Oxidative inactivation of Prxs was apparently advantageous during the evolution of eukaryotes, which use hydrogen peroxide as a signaling molecule (8) . This mechanism allows hydrogen peroxide to halt peroxidase while passing its message to redox-sensitive components of signaling pathways (8, 14) . However, after the peroxide signal is conveyed, the impaired antioxidant firewall needs to be promptly reestablished to prevent oxidative stress. Indeed, gradual recovery of Prxs has been detected after initial oxidative inactivation (13, 15, 16) , and an enzyme catalyzing adenosine triphosphate (ATP)-dependent regeneration of Cys-SO 2 H, sulphiredoxin (Srx), has been detected in yeast (17) . However, a similar activity remains to be identified in mammals and other animals in which the rate of regeneration of Prxs is critical for modulation of peroxide signaling and thus for cell-specific responses to oxidative stress. We have recently shown that overexpression of the p53-regulated gene Hi95 (18) , a member of the sestrin gene family (19) , protects cells against apoptosis induced by ischemia or H 2 O 2 , suggesting that Hi95 is involved in defense against ROS (18) . To gain insight into the functions of sestrins [Hi95, PA26 (20) , and Sesn3], we undertook a detailed sequence analysis of these proteins (21) . An iterative database search performed with the use of the PSI-BLAST program (22) revealed statistically significant sequence similarity (random expectation value, E ϳ 0.001) between a conserved region in the N-terminal part of the sestrins and a family of prokaryotic proteins, which includes the Mycobacterium tuberculosis AhpD, an enzyme that catalyzes reduction of the peroxiredoxin AhpC (23, 24 ) . The presence of a domain with a fold common to the AhpD family proteins and the sestrins was confirmed by threading analysis using the 3D-PSSM program (25) . The homology spans at least the five Nterminal ␣-helices of the conserved region of the sestrins and the C-terminal ␣-helical domain of AhpD (23, 24 ) . The structural and evolutionary autonomy of the conserved domain is supported by the fact that certain members of the AhpD family, such as caroboxymuconolactone decarboxylases, consist of this domain alone (Fig.  1) . However, only the proximal cysteine of the essential cysteine dyad of AhpD (26 ) is conserved in sestrins.
AhpD is a component of alkylhydroperoxide reductase, which in M. tuberculosis takes part in the defense against oxidative and nitrosative components of the host immune response (24 ) . AhpD is responsible for regeneration of Prx AhpC, which is oxidized during reduction of peroxides and RNS (4, 24, 26 ) . The homology of sestrins and AhpD and the indirect link of Hi95 to the regulation of ROS homeostasis (18) suggested that, like AhpD, sestrins might be redox enzymes catalyzing regeneration of Prxs. In AhpD, both cysteines of the Cis-Ser-His-Cys motif ( Fig. 1 ) are essential for redox activity, with the distal cysteine directly involved in the nucleophilic attack on the substrate and the proximal cysteine catalyzing the resolution of the reaction intermediate via formation of an intramolecular disulfide bond in AhpD.
To determine whether Hi95 and PA26 affect hydrogen peroxide amounts in cell cul- ture, we inhibited expression of Hi95 or PA26 more than 50-fold with the use of small interfering RNAs (siRNAs) (Fig. 2A) . The level of intracellular ROS determined by dichlorodihydrofluorescein (DCF) fluorescence 48 hours after introduction of sestrin siRNAs was significantly increased compared to control cells, regardless of pretreatment with 500 M H 2 O 2 (Fig. 2B and fig. S3, A and B) . Knocking down expression of Hi95 also compromised the ability of cells to detoxify RNS generated after treatment with NO donors ( fig. S3C ). By contrast, overexpression of Hi95 and PA26 cDNAs lead to a notable reduction in ROS (Fig. 2, C to E, and figs. S3D and S4).
Inhibition of Hi95 or PA26 negatively affected the growth rate and viability of the cells (Fig.  3 and fig. S6 ), especially after introduction of siRNA to PA26, which resulted in deterioration of the cultures within a week (Fig. 3A and fig.  S6A ). Inhibition of Hi95 in human embryonic fibroblasts (HEFs) resulted in slower proliferation, expression of senescence-associated ␤-galactosidase, and a dramatic increase in p53 ( fig.  S6B) . In RKO cells, inhibition of Hi95 elicited notable sensitization to H 2 O 2 -induced apoptosis, which contrasts with the increase in resistance after overexpression of Hi95 or PA26 cDNAs (Fig. 3C) .
We next tested the role of the cysteine that is conserved between sestrins and AhpD in the apparent redox function of sestrins. Replacement of the conserved Cys 125 of Hi95 or Cys 130 of PA26 with serine resulted in complete loss of the sestrins' ability to decrease intracellular ROS (Fig. 2E) and to protect against cell death after (fig. S6C) . Moreover, overexpression of the mutant proteins resulted in an increase in ROS and a decrease in viability after H 2 O 2 treatment, possibly because of their dominant-negative effect (Fig. 2E and fig. S6C) Given the homology with AhpD, it seemed likely that sestrins function similarly in the Prx pathway. Alternatively, however, the ability of sestrins to down-regulate peroxides could be because of their participation in other antioxidant systems. In eukaryotes, glutathione peroxidase controls peroxide amounts in addition to and independently of the Prxs. Unlike Prxs, which function in conjunction with the thioredoxin reductase (TrxR) system (2), glutathione peroxidase is reduced by glutathione (27) . Treatment of RKO cells with buthioninesulfoximine (BSO), which depletes intracellular glutathione (28), or with the TrxR inhibitor 2,4-dinitro-1-chlorobenzene (DNCB) (29) resulted in an increase in intracellular ROS. However, in Hi95-deficient cells, only treatment with BSO produced an additional increase in ROS (Fig. 4A) , suggesting that Hi95 is functionally coupled to TrxR rather than to glutathione.
To investigate whether the sestrins directly regulate Prxs, we examined whether Hi95 and PA26 interact with Prxs in the cell. Confocal microscopy after immunofluorescent staining revealed strict colocalization of PrxI with exogenously expressed Hi95 and PA26 in MCF7 cells, whereas there was no colocalization of Hi95 with mitochondrial PrxIII (Fig. 4B and fig. S7A ). In immunoprecipitation experiments, antibodies to both PA26 and Hi95 precipitated PrxI equally efficiently in H 2 O 2 -treated and untreated cells (Fig. 4C  and fig. S7B ).
To evaluate the effect of sestrins on the redox state of Prxs, we measured the proportion of the native and Cys-SO 2 H forms of Prx on twodimensional (2D) gels (9, 10 (Fig. 4D) . The difference was less significant when the cells were allowed to recover for 6 hours after H 2 O 2 treatment, which correlated with the induction of endogenous PA26 and Hi95 ( fig. S5) . A similar effect of sestrins was observed for PrxII ( fig. S8A ).
To test whether sestrins are directly involved in regeneration of Prxs, we assayed the activity of immunopurified Hi95Flag protein in vitro with the use of H 2 O 2 -pretreated PrxI. Incubation with Hi95Flag protein in the presence of ATP, MgCl 2 , and dithiothreitol (DTT) resulted in notable reduction of PrxI, whereas purified Ser 125 -Hi95Flag mutant protein was inactive; the reduction required ATP and MgCl 2 (Fig. 4E) . Thus, the activity of Hi95 is sufficient to catalyze reduction of PrxI in vitro, indicating that Hi95 is an essential, although perhaps not the only, component of cysteine sulfinyl reductase. In yeast that does not have sestrins, regeneration of Prx is catalyzed by Srx (17). We overexpressed recombinant human Srx ortholog in RKO and MCF7 cells and observed notable decrease in ROS after H 2 O 2 treatment (30). However, in the in vitro assay, purified recombinant human Srx protein did not reduce PrxI and did not affect the reaction catalyzed by Hi95 when added in an equimolar amount ( fig. S8C) . Hence, the human Srx either functions in a separate pathway of ROS regulation or plays an auxiliary role in Prxs regeneration mediated by sestrins.
Our results indicate that, whereas Hi95 and PA26 do not protect Prxs from initial overoxidation after a peroxide burst, they substantially increase the rate of recovery of the overoxidized Prxs. Thus, sestrins appear to catalyze the reduction of Prxs in a manner that is functionally analogous to but mechanistically distinct from the role of AhpD in the AhpD/AhpC complex. Being a robust peroxidase, AhpC does not form overoxidized species, and, accordingly, AhpD acts as a disulfide reductase. In Prxs, the disulfides formed during background scavenging are reduced by thioredoxin. However, to reactivate the overoxidized form produced after peroxide bursts, cysteine sulfinyl reductase activity is required. Therefore, concomitantly with evolution of two-stage oxidation of Prxs in eukaryotes, which allows peroxide signaling, the redox activity of AhpD/sestrins apparently underwent a qualitative change to meet the new requirements.
Inactivation of Prxs by overoxidation during physiological signaling opens a gateway for peroxide-dependent signals (8, 14) , allowing the peroxides to circumvent antioxidant control mechanisms. However, this gateway then needs to be closed to prevent development of oxidative stress. Our findings indicate that sestrins play a major role in reestablishing the antioxidant firewall. Modulation of sestrin expression by p53 might be part of an adaptive response mechanism that protects the cell against oxidative stress. In addition, substantial variations in the expression of PA26 and Hi95 in different tissues (18, 20) might be responsible for tissue-specific differences in peroxide-dependent signaling and for variability in the effects of elevated ROS and RNS. Lastly, modulation of sestrins' activity may have promising therapeutic implications for ROS-related pathologies. Cystic fibrosis is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). The most common mutation, ⌬F508, results in the production of a misfolded CFTR protein that is retained in the endoplasmic reticulum and targeted for degradation. Curcumin is a nontoxic Ca-adenosine triphosphatase pump inhibitor that can be administered to humans safely. Oral administration of curcumin to homozygous ⌬F508 CFTR mice in doses comparable, on a weight-per-weight basis, to those well tolerated by humans corrected these animals' characteristic nasal potential difference defect. These effects were not observed in mice homozygous for a complete knockout of the CFTR gene. Curcumin also induced the functional appearance of ⌬F508 CFTR protein in the plasma membranes of transfected baby hamster kidney cells. Thus, curcumin treatment may be able to correct defects associated with the homozygous expression of ⌬F508 CFTR.
The ⌬F508 CFTR mutation accounts for ϳ69% of all cystic fibrosis (CF) alleles, and ϳ90% of CF patients carry at least one copy of ⌬F508 CFTR (1). Although it is functional as a chloride channel (2), the misfolded ⌬F508 CFTR protein is retained in the endoplasmic reticulum (ER) through interactions with elements of the ER's quality control chaperone machinery and targeted for subsequent degradation in the proteasome (3) (4) (5) . Many ER lumen chaperones are calcium-binding proteins (6, 7 ), suggesting the possibility that treatments capable of reducing the concentration of calcium in the ER lumen might interfere with chaperone function and thus permit ⌬F508 CFTR to escape. Incubation of human cell lines expressing ⌬F508 CFTR with sarcoplasmic/endoplasmic reticulum calcium pump (SERCA) inhibitors results in the release of the ER-retained ⌬F508 CFTR protein, permitting it to achieve its characteristic functional residence at the cell surface (8) . To identify nontoxic compounds that may work through similar mechanisms, we tested the capacity of curcumin, a relatively low-affinity SERCA pump inhibitor (apparent K i ϳ 5 to 15 M) (9-11), to correct aspects of the CF defect in cell lines and mice expressing ⌬F508 CFTR. To determine whether oral curcumin treatment could safely effect the functional redistribution of the ⌬F508 protein in the context of a living CF-affected organism, genetargeted mice homozygous for the ⌬F508 mutation were given 45 mg of curcumin per kilogram of body weight by mouth daily for 3 days. The dose administered was chosen to approximate, on a weight per weight basis, curcumin doses that have been well tolerated in humans in previous studies (12) . The curcumin was given either as a once per day bolus or as a divided dose three times daily. Following treatment, the membrane potential difference across the nasal epithelia [nasal potential difference (NPD)] was measured (13) . In untreated CF-affected animals the nasal epithelium exhibited a large, lumennegative potential that was sensitive to amiloride, reflecting electrogenic Na ϩ absorption (Fig. 1A) (8, 14) . Removal of luminal Cl -and exposure to isoproterenol did not substantially alter the potential in untreated ⌬F508 animals (15, 16) . After curcumin treatment, the average baseline NPD decreased from -27.9 Ϯ 0.77 mV to -10.8 Ϯ 0.62 mV, approaching the values in wild-type mice (-8.36 Ϯ 0.55 mV). In addition, perfusion with the low Cl -solution and subsequent addition of isoproterenol each resulted in hyperpolarizations of the NPD similar to those seen with wild-type animals (Fig.  1A) . Thus, there was a correction of both the baseline and isoproterenol-stimulated components of the NPD trace after treatment with orally administered curcumin. In contrast, phenylbutyrate treatment of the CF mice produced an effect only on the isoproterenol-stimulated component, consistent with what has been observed in human clinical trials (17 ) (fig. S1 ).
To test the specificity of these effects for ⌬F508 CFTR, curcumin was administered to homozygous CFTR knockout mice (18, 19) . These animals do not express any CFTR protein but retain the remaining complement of transport systems that is associated with epithelial fluid and electrolyte secretion. We found that curcumin treatment did not correct the abnormal NPD measured in the CFTR knockout mice (Fig. 1B) .
To assess whether curcumin altered intestinal ion transport, we measured the rectal potential difference (RPD) in ⌬F508 CF mice before and after treatment with curcumin. RPD measurements obtained from ⌬F508 CF mice differ in two major characteristics from those derived from wild-type littermates (20) . First, the baseline RPD of the ⌬F508 CF mice is less negative than the baseline RPD of the wild-type mice. Furthermore, the RPD of wild-type mice, but not ⌬F508 CF mice, hyperpolarizes in response to forskolin. The lack of response in the CF animals is believed to result from the absence of functional CFTR in the rectal mucosa. We found that after treatment with curcumin, the CF mice had a 4.46 Ϯ 1.0 mV hyperpolarization in response to forskolin (Fig. 2A) . This response is approximately 91% of the response observed in the wild-type and heterozygote mice examined in this study.
We examined the processing of ⌬F508 CFTR protein expressed in the baby hamster kidney (BHK) cell line. The ER-retained ⌬F508 CFTR protein is core-glycosylated (4), whereas wild-type CFTR acquires complex glycosylation (4, 21) . Incubation of BHK cells expressing
